head-img
head-img

This product information is intended for healthcare professionals in the European Union only.


  • About stage III NSCLC
  • MOA
  • Efficacy
  • PD-L1 TESTING
  • SAFETY
  • Dosing
  • Interactive Case Studies
  • Supporting Materials
  • More Hide

    SITEMAP

    Home

    About NSCLC

    MOA

    Efficacy

    PD-L1 testing for The PACIFIC Regimen

    Safety

    Dosing

    Interactive Case Studies

    Support Materials

    Thank you for visiting the AstraZeneca Medicines website

    This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

    Do you wish to continue?

    Cancel Continue

    Thank you for visiting the AstraZeneca Medicines website

    This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

    Do you wish to continue?

    Cancel Continue
     

    Validating...

    Welcome to AstraZeneca Medicines UK

    The content on this website is intended for UK Healthcare Professionals only. The website contains both promotional and non-promotional content.

    I am not a UK Healthcare Professional

    Welcome to the AstraZeneca Medicines Site

    Sorry, your web browser is not supported

    Unfortunately, you are using an unsupported browser. Please use Google Chrome 52.0 or Internet Explorer 11 or later. Apologies for any inconvenience.

    GB-6911 - June 2017

    Cancel

    IMFINZI is a trademark of theAstraZeneca group of companies.

    ©2020 AstraZeneca. All rights reserved.

    Date of preparation : October 2020 –GB-22976


    • AstraZeneca Global Corporate Site

    • Privacy Notice
    • Legal Notice and Terms of Use

    • Site Map
    • Cookie Policy

    • Prescribing Information

    • Contact Us
     

    Loading......


    • AstraZeneca Global Corporate Site
    • Privacy Notice
    • Legal Notice and Terms of Use
    • Site Map
    • Cookie Policy
    • SmPC
    • Adverse Event Reporting

    IMFINZI is a trademark of theAstraZeneca group of companies.
    ©2018 AstraZeneca. All rights reserved.
    Date of preparation: November 2018—VPM ID: Z4-9547—Expiry date: November 2019